We are live on ! Find out more
CRVS icon

Corvus Pharmaceuticals

47 hedge funds and large institutions have $18.5M invested in Corvus Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 13 increasing their positions, 10 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more call options, than puts

Call options by funds: $80K | Put options by funds: $60K

30% more repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 10

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

3.86% less ownership

Funds ownership: 58.87%55.01% (-3.9%)

18% less funds holding

Funds holding: 5747 (-10)

59% less capital invested

Capital invested by funds: $44.9M → $18.5M (-$26.5M)

69% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 13

Holders
47
Holders Change
-10
Holders Change %
-17.54%
% of All Funds
0.79%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
4
Increased
13
Reduced
10
Closed
13
Calls
$80K
Puts
$60K
Net Calls
+$20K
Net Calls Change
+$183K
Name Holding Trade Value Shares
Change
Change in
Stake
Walleye Capital
51
Walleye Capital
New York
-$25K -15,080 Closed
VF
52
Virtu Financial
New York
-$23K -14,269 Closed
CSS
53
Cubist Systematic Strategies
Connecticut
-$11K -6,600 Closed
US Bancorp
54
US Bancorp
Minnesota
-$8K -5,153 Closed
CG
55
Cutler Group
California
-$7K -4,700 Closed
Bank of America
56
Bank of America
North Carolina
-$1.31K -1,067 -70%
Wells Fargo
57
Wells Fargo
California
+$267 +218 New
TCWM
58
Total Clarity Wealth Management
Illinois
+$613 +500 New